Company News in the Life Science Industry

»

Reset 

Athersys Provides Update on One-Year ARDS Study Data

Read more ››
By: GlobenewsWire - 14 Jan 2020
Related companies:  Athersys, Inc.

Valneva: US DoD Exercises Option on IXIARO® Supply Contract Bringing Total Value to $70 Million

Read more ››
By: GlobenewsWire - 14 Jan 2020

Innovent Out-Licenses Commercial Rights for Avastin® Biosimilar to Coherus BioSciences in the United States and Canada

SUZHOU, China, Jan. 14, 2020 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or the "Company") (HKEX: 01801), a biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, today announced... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2020
Related companies:  Innovent Biologics Co., Ltd. | Coherus BioSciences, Inc.

Genome & Company announces a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer

SEOUL, South Korea, Jan. 14, 2020 /PRNewswire/ -- Genome & Company (KONEX: 314130) is pleased to announce that it has entered into a clinical trial collaboration and supply agreement with Merck KGaA, Darmstadt, Germany and Pfizer Inc. to evaluate the safety, tolerability, biological and clinical... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2020

Gary F. Moore, M.D. F.A.C.S. is recognized by Continental Who's Who

OMAHA, Neb., Jan. 13, 2020 /PRNewswire/ -- Gary F. Moore, M.D. F.A.C.S. is being recognized by Continental Who's Who as a Pinnacle Lifetime Achiever in the field of medicine as a Doctor in Neurotology. Dr. Moore also has expertise in Otolaryngology, skull vase surgery, balance, hearing loss,... Read more ››

By: PR Newswire Association LLC. - 14 Jan 2020

PhaseBio Announces Acquisition of Novel Oral Aldosterone Synthase Inhibitor to Develop for Treatment-Resistant Hypertension

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  PhaseBio Pharmaceuticals Inc.

Codexis Attends Opening Ceremony for Porton’s Fermentation Pilot Lab in Chongqing

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Codexis, Inc.

IRIDEX Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2019

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  IRIDEX Corporation

RTI Surgical Holdings, Inc.® Announces Sale of OEM Business and Preliminary Fourth Quarter and Full Year 2019 Revenues

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  RTI Surgical, Inc.

Stemline Therapeutics Announces Preliminary 2019 Net Revenues for ELZONRIS® (tagraxofusp) and Highlights Commercial and Clinical Growth Drivers

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Stemline Therapeutics, Inc.

French Regulatory Agency Agrees lacutamab TELLOMAK Trial Can Resume Recruitment in Sezary Syndrome and mycosis fungoides

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Innate Pharma S.A.

Precipio announces shareholder update call to kick off 2020

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Precipio Diagnostics

Helix BioPharma Corp. Closes $3.0 Million Private Placement

Read more ››
By: GlobenewsWire - 13 Jan 2020
Related companies:  Helix Biopharma Corp.

Evolution 2.0 Prize: Unprecedented $10 Million Offered To Replicate Cellular Evolution

CHICAGO, Jan. 14, 2020 /PRNewswire/ -- An incentive prize ten times the size of the Nobel - believed to be the largest single award ever in basic science - is being offered to the person or team solving the largest mystery in history: how genetic code inside cells got there, and how cells intentionally... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Global Rehabilitation Robots Market Study; 2017-2019, 2023 and 2027 - Includes Company Profilings with Detailed Strategies, Financials and Recent Developments

DUBLIN, Jan. 13, 2020 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020

Sale of Global Leader in Joint Preservation Incubated at Primo Medical Group

STOUGHTON, Mass., Jan. 13, 2020 /PRNewswire/ -- Primo Medical Group, a Massachusetts based medical device manufacturer and incubator, is pleased to announce the sale of its spin-off company Arthrosurface, to Anika Therapeutics.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020
Related companies:  Anika Therapeutics, Inc.

The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018

NEW YORK, Jan. 13, 2020 /PRNewswire/ -- The North America hereditary cancer testing market is expected to reach US$ 3,247.37 Mn in 2027 from US$ 1,255.79 Mn in 2018. This market is projected to grow at a growth rate of 11.6% from 2019-2027.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020

NABH Comments on CMS' New Survey and Certification Process for Psychiatric Hospitals

WASHINGTON, Jan. 13, 2020 /PRNewswire/ -- The Centers for Medicare & Medicaid Services (CMS) on Monday announced it has streamlined the process to survey the nation's psychiatric hospitals to review for compliance with participation requirements in one comprehensive survey.

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020

The global peripheral guidewires market at a CAGR of almost 7% during the forecast period

NEW YORK, Jan. 13, 2020 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 13 Jan 2020

John Theurer Cancer Center Investigators Report Effectiveness of New Treatment for Refractory Multiple Myeloma

HACKENSACK, N.J., Jan. 13, 2020 /PRNewswire/ -- Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey were part of the CANDOR global phase III clinical trial for patients with refractory (persistent) multiple myeloma. The study was selected as the prestigious... Read more ››

By: PR Newswire Association LLC. - 13 Jan 2020
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14 15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies